Auto-generated from public data. Not the firm's stated position.
Accurafy 4 appears to focus on early-stage European ventures spanning fintech, digital health, and alternative assets, with a particular interest in technology-enabled solutions that intersect financial services and sustainability. Recent portfolio activity suggests an investment thesis oriented toward tokenization, digital health accessibility, and nature-based financial products across pre-seed through Series B stages.
Generated 6 Oct 2026 from disclosed sectors, stages, and portfolio companies. Firms can update this by emailing [email protected].
Focus and check size from the firm's website. Website reachable as of Oct 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.